"69101-505-30" National Drug Code (NDC)

Consensi 30 TABLET in 1 BOTTLE (69101-505-30)
(Burke Therapeutics, LLC)

NDC Code69101-505-30
Package Description30 TABLET in 1 BOTTLE (69101-505-30)
Product NDC69101-505
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NameConsensi
Non-Proprietary NameAmlodipine Besylate And Celecoxib
Dosage FormTABLET
UsageORAL
Start Marketing Date20191217
End Marketing Date20221231
Marketing Category NameNDA
Application NumberNDA210045
ManufacturerBurke Therapeutics, LLC
Substance NameAMLODIPINE BESYLATE; CELECOXIB
Strength5; 200
Strength Unitmg/1; mg/1
Pharmacy ClassesAnti-Inflammatory Agents, Non-Steroidal [CS], Calcium Channel Antagonists [MoA], Cyclooxygenase Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Nonsteroidal Anti-inflammatory Drug [EPC]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/69101-505-30